The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways
Abstract
MicroRNAs have essential functional roles in brain development and neuronal specification but their roles in neurodegenerative diseases such as Alzheimer's disease (AD) is unknown. Using a sensitive qRT-PCR platform we identified regional and stage-specific deregulation of miRNA expression in AD patient brains. We used experimental validation in addition to literature to reveal how the deregulated brain microRNAs are biomarkers for known and novel pathways in AD pathogenesis related to amyloid processing, neurogenesis, insulin resistance, and innate immunity. We additionally recovered miRNAs from cerebrospinal fluid and discovered AD-specific miRNA changes consistent with their role as potential biomarkers of disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We detected a relatively smaller number of miRNAs in CSF, compared to other miRNA profiling studies19,28.”
From Intra- and Inter-individual Variability of microRNA Levels in Human Cerebrospinal Fluid: Critical Implications for Biomarker Discovery (2017) · cites this paper as [28]
In the citing paper
“Although the level of miR-9-5p was downregulated in AD brains and EVs from CSF [47,48,49]”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“Similar to miR-146a-5p, miR-132-3p was reported to be downregulated in AD in five independent studies [48,72,80,84] but up-regulated in AD in only one independent study [81].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“Among these miRNAs, miR-146a-5p [50,70,73,74,83] and miR-132-3p [48,72,80,81,84] were reported to be dysregulated in six independent AD studies, respectively.”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“miR-125b-5p was upregulated in brains [36,48,50] and EVs from CSF of AD patients compared to HC [49,66].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“Substantial recent evidence has demonstrated that microRNAs (miRNAs) are dysregulated already early on in AD pathology [2–7].”
From microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer’s disease patients (2026) · cites this paper as [4]
In the citing paper
“miR-92a-1-5p expression in AD brain is enhanced, while miR-501-3p expression is increased in both brain and serum of AD patients [41–43].”
From Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability (2025) · cites this paper as [43]
In the citing paper
“miR-92a-1-5p expression in AD brain is enhanced, while miR-501-3p expression is increased in both brain and serum of AD patients [41–43].”
From Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability (2025) · cites this paper as [43]
In the citing paper
“Both miRNAs are expressed in the human brain and are deregulated in AD [41–43, 54].”
From Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability (2025) · cites this paper as [43]
In the citing paper
“Many studies have detected extracellular/circulating miRNAs in biological fluids, such as plasma and serum (117, 118), cerebrospinal fluid (119), saliva (120), breast milk (121), urine, tears, colostrum, peritoneal fluid, bronchial lavage, seminal fluid (122), and ovarian follicular fluid (123).”
From Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation (2018) · cites this paper as [119]
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,989
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S., Großhans, H., Shingara, J., Byrom, M., JARVIS, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,699
MicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,153
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
Flagged first, then by citations
1 of the 65 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–945 of 945
Prediction of Post-Stroke Cognitive Impairment by Serum miR-124, miR-132, miR-134
Li, L. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12101309
(2022) · Stem Cell Research International · doi:10.33140/scri.06.02.01
Adapting Genome-wide microRNA Discovery and Target Prediction to Specific Species
Ajila, V. (2023) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2023-15614
miR-122 and miR-21 as clinical biomarkers in hepatocellular carcinoma: A review
Kumar, N., Choudhary, P., Sharma, N., Tripath, A., & Sharma, R. (2023) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2023.148309
Three Neurodegenerative Diseases: A Single Hope
Youssef, S. H., Atalah, H. N., Badawy, M. T., El‐Fawal, H. A. N., & Salama, M. (2023) · Springer eBooks · doi:10.1007/978-981-19-3949-5_3-1
Korkut, Ş. V. (2023) · International journal of medical biochemistry/International journal of medical biochemistry : · doi:10.14744/ijmb.2023.43043
The role of microRNA-325-3p as a critical player in cell death in NSCs and astrocytes
Lee, Y., Lee, S.-W., Jeong, D., Lee, H., & Ko, K. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1223987 · Cited by 1
miRNA jako potencjalne biomarkery padaczki u dzieci
Rzepka-Migut, B., & Paprocka, J. (2024) · Child Neurology · doi:10.5603/cn.99009
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Figshare · doi:10.6084/m9.figshare.14945066
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Figshare · doi:10.6084/m9.figshare.14945063
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Figshare · doi:10.6084/m9.figshare.14945060
miRNAs As Biomarkers for Neurodegenerative Diseases
Gallardo‐Pérez, M. M., & Garcés‐Eisele, S. J. (2024) · Epigenetics and human health · doi:10.1007/978-3-031-64788-8_7
Machine learning uncovers novel sex-specific dementia biomarkers linked to autism and eye diseases
Khan, A., Ghasemi, A. R., Ingram, K. K., & Ay, A. A. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251317177
The involvement of microRNAs in Multiple Endocrine Neoplasia type 1
Aurilia, C., & Iantomasi, T. (2025) · International Journal of Bone Fragility · doi:10.57582/ijbf.240403.108
Sun, X., Dai, L., Yuan, X., Cheng, L., Wang, J., Tian, Y., & Zhou, L. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf044
Epigenetics and pharmacoepigenetics of age-related neurodegenerative disorders
Cacabelos, R., Martínez-Iglesias, O. A., Cacabelos, N., Cacabelos, P., & Naidoo, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18722-3.00032-3
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088344
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088338
Shigemizu, D., Akiyama, S., Higaki, S., Sugimoto, T., Sakurai, T., Boroevich, K. A., Sharma, A., Tsunoda, T., Ochiya, T., Niida, S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13219377
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088329
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088332
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088335
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088347
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088317
Dakterzada, F., Targa, A., Benítez, I. D., Romero, L., de Gonzalo‐Calvo, D., Torres, G., Moncusí‐Moix, A., Huerto, R. P., Sánchez-de-la-Torre, M., Barbé, F., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13337708
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088323
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088341
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088326
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088314
Wallach, T., Mossmann, Z. J., Szczepek, M., Wetzel, M., Machado, R. S. R., Raden, M., Miladi, M., Kleinau, G., Krüger, C., Dembny, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17088350
Güven, G., Lohmann, E., Güleç, Ç., Bilgiç, B., Özer, E., Hanagasi, H. A., Gurvit, H. I., & Erginel‐Ünaltuna, N. (2020) · DergiPark (Istanbul University)
MXene–Protein Corona Interfaces for Molecular Profiling of Alzheimer’s Disease
Velazquez, S., Juber, M. C., Brindley, D., Thakur, A., Anasori, B., Lau, E., & Ashkarran, A. A. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c01228
Wang, R., Maloney, B., Nho, K. T., Beck, J. S., Counts, S., & Lahiri, D. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.11.731747
Targeting mtDNA to Modulate Mitochondrial Dysfunction in Neurodegenerative Diseases
Pramanik, S., Debnath, B., Chakraborty, A. J., Islam, A., Mullick, S., Chaudhary, P., Nath, R., Chellappan, D. K., Mondal, M., & Ashique, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06008-2
Computational Methods for Pathway and Network Analysis with MicroRNAs
Alaimo, S., & Pulvirenti, A. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5392-0_8
Non-coding RNAs and Mitochondrial Dysfunction in Alzheimer’s Disease: A Systematic Review
Mocrei-Rebrean, Ș.-M., Răzniceanu, V., Pintilie, S. R., & Berindan‐Neagoe, I. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06198-9
Epigenetic mechanisms in brain development and in neurodegeneration
MA, Y., CHEN, K. W., & JAGER, P. D. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19043-8.00030-x
FAIRsharing record for: Extracellular RNA Atlas
FAIRsharing Team, Thistlethwaite, W., et al. (2018) · FAIRsharing.org · doi:10.25504/fairsharing.xcvp6a
López, Á., & Jesús, M. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Kim, S., & Jazwinski, S. M. (2015) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6678-8_8
Erikçi, E. (2014) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4736
microRNA Function and Dysregulation in Depression and Suicide
Dwivedi, Y. (2014) · Springer eBooks · doi:10.1007/978-3-319-09964-4_17
The Epigenetics of Alzheimer’s Disease
Coppedè, F. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-388415-2.00009-3
Metadata
- Authors
- Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., Prinjha, R. K., Richardson, J. C., Saunders, A. M., Roses, A. D., & Richards, C. A.
- Affiliations
- GlaxoSmithKline (United States) (US)
- Asuragen (United States) (US)
- Molecular Cell Biology-RandD, Applied Biosystems Foster City, CA, USA
- GlaxoSmithKline (United Kingdom) (GB)
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2008-05-09
- Volume
- 14
- Issue
- 1
- Pages
- 27-41
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W32204808
- Cited by
- 943
- References
- 65
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 28 · 2023: 35 · 2022: 50 · 2021: 78 · 2020: 62 · 2019: 60 · 2018: 69 · 2017: 65 · 2016: 64 · 2015: 83 · 2014: 71 · 2013: 74 · 2012: 50
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GlaxoSmithKline
- National Institute on Aging (NIA AG05128)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, microRNA
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Amyloid, Brain, Cerebellum, Female, Frontal Lobe, Gene Expression Regulation, Genetic Markers, Hippocampus, Humans, Immunity, Innate, Insulin Resistance, Male, Middle Aged, Neurons, RNA, Messenger, Transfection, Biomarkers, Reverse Transcriptase Polymerase Chain Reaction, MicroRNAs, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
